Sao Tome and Principe vs Zambia: Enforcing contracts: Alternative dispute resolution (0-3)
Enforcing contracts: Alternative dispute resolution (0-3) over time
- Sao Tome and Principe
- Zambia
How they compare
Sao Tome and Principe currently reports 1.5 DB16-20 methodology against 1.5 DB16-20 methodology in Zambia, a difference of 0 DB16-20 methodology.
Across all 5 years both countries report, Zambia has been ahead every year.
Sao Tome and Principe ranks 170th and Zambia ranks 170th of 191 countries.
Frequently asked questions
- Which has higher enforcing contracts: alternative dispute resolution (0-3), Sao Tome and Principe or Zambia?
- Sao Tome and Principe, at 1.5 DB16-20 methodology against 1.5 DB16-20 methodology in Zambia as of 2019.
- What is the difference in enforcing contracts: alternative dispute resolution (0-3) between Sao Tome and Principe and Zambia?
- 0 DB16-20 methodology, with Sao Tome and Principe ahead.
- How many years of comparable data are there for Sao Tome and Principe and Zambia?
- 5 years are reported by both, from 2015 to 2019.
- How do Sao Tome and Principe and Zambia rank globally for enforcing contracts: alternative dispute resolution (0-3)?
- Sao Tome and Principe ranks 170th and Zambia ranks 170th of 191 countries.
- Where does this data come from?
- The World Bank, published as Enforcing contracts: Alternative dispute resolution (0-3) (DB16-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The alternative dispute resolution evaluates two aspects: (i) whether domestic commercial arbitration is regulated by law, all disputes can be submitted to arbitration and valid arbitration clauses are usually enforced by courts; and (ii) whether voluntary mediation and/or conciliation are a recognized way of resolving commercial disputes, they are regulated by law and there are financial incentives for parties to attempt mediation of conciliation. The index is computed based on the methodology in the DB17-20 studies.